Day Three Labs

Pharmaceutical-grade Cannabinoid Infusion Technology

Health Tech & Life Sciences
Non Active, Mar 2024 ceased to operate
Follow

Company Overview

Snapshot

Founded in November 2021 by Josh Rubin and Rafi Cohen, Day Three Labs operates with 1–10 employees. The company has raised $6.08M across three funding rounds from four investors. In January 2022, Day Three Labs acquired a revolutionary pharmaceutical-grade cannabinoid infusion technology.

Business overview

Day Three Labs is a cannabinoid CPG ingredient manufacturer focused on developing and commercializing novel cannabis product solutions. The company's core product, Unlokt, is an ingestible cannabinoid remedy that utilizes a natural protein to shuttle cannabis directly into circulation, protecting terpenes and cannabinoids while bypassing first-pass metabolization. Day Three Labs serves the health tech and life sciences sectors, specifically within pharma and medical biotechnology, with a focus on medical cannabis.

Strategic signal

In February 2023, Day Three Labs announced a breakthrough in unlocking the potential of edible cannabis, signaling advancements in cannabinoid delivery and bioavailability. This development suggests a strategic focus on enhancing the efficacy and consumer experience of cannabis-infused products, which could significantly impact the medical cannabis and CPG markets by offering more reliable and predictable dosing.

Log in to access full profile

Company Intelligence Q&A

What is Day Three Labs' primary focus?
Day Three Labs specializes in developing and commercializing novel cannabis product solutions as a cannabinoid CPG ingredient manufacturer.
When was Day Three Labs founded?
Day Three Labs was founded in November 2021.
What is Unlokt?
Unlokt is an ingestible cannabinoid remedy developed by Day Three Labs that uses a natural protein to deliver cannabis directly into circulation, bypassing first-pass metabolization.
What significant technology acquisition did Day Three Labs make?
In January 2022, Day Three Labs acquired a revolutionary pharmaceutical-grade cannabinoid infusion technology.
What was a recent development regarding edible cannabis?
In February 2023, Day Three Labs announced a breakthrough that unlocks the potential of edible cannabis, indicating advancements in its delivery and efficacy.
Log in to access full profile